Your missing links are here (9 October 2020)

Some of the best stuff we picked up around the internet

By: Karen O'Hanlon Cohrt - Oct. 9, 2020

Top Picks

Research

  • Researchers in Spain target fusion oncogenes in cancer cells with CRISPR-Cas9. Targeting these tumour-specific genes is an attractive approach to tackling cancer, and the researchers show proof-of-concept for this strategy in mice that developed tumours following injection with a human Ewing sarcoma cell line.

Industry

Delivery & Safety

COVID-19

Reviews and Opinion

Awards & Funding

Tags

HashtagArticleHashtagMissing linksHashtagNews

CLINICAL TRIALS
Non-small Cell Lung Cancer,NSCLC, (NCT03525782)
Sponsors:
First Affiliated Hospital of Guangdong Pharmaceutical University
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Prostate Cancer, (NCT03525652)
Sponsors:
The First Affiliated Hospital of Guangdong Pharmaceutical University
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine